DePuy Synthes Companies, AO Foundation sign cooperation agreement to improve patient outcomes

NewsGuard 100/100 Score

The DePuy Synthes Companies of Johnson & Johnson today announced that the company has signed a five-year cooperation agreement with the AO Foundation to continue the work they began together in 1960 to deliver world-class professional education and develop new innovations that improve patient outcomes and increase efficiency of care.

Through the agreement, DePuy Synthes Companies will be the key industry partner for the AO Technical Commission (AOTK) for each of its specialty areas: trauma and corrective surgery of the musculoskeletal system, spine, craniomaxillofacial, veterinary products and related instruments and implants. The AO Specialties continually redefine the state-of-the-art in their respective fields, maintaining activities in research, development, clinical investigation and education.

The two independent organizations will collaborate on innovation and certification of new DePuy Synthes Companies products by AOTK that will then be used in AO educational activities. More than 200,000 health care professionals are expected to participate in AO programs globally over the next five years.

The AO Foundation, founded in 1958, provides professional education to an extensive global network of surgeons, operating room personnel, and scientists in more than 100 countries. Since DePuy Synthes Companies and the AO began collaborating in 1960, a substantial investment has been made in research, development and education. In addition, vital training including direct hands-on courses has been provided to more than 450,000 surgeons and 150,000 operating room professionals from 124 countries around the world.

“The AO Foundation and DePuy Synthes Companies have maintained a strong relationship for 55 years because of a shared passion for advancing patient care,” said Ciro Roemer, Company Group Chairman, DePuy Synthes Companies International Markets. “Bringing together the unique perspectives of

DePuy Synthes Companies and the AO will help us accurately identify and effectively solve the most pressing clinical issues in musculoskeletal surgery and then teach clinicians to appropriately use those solutions.”

Through this cooperation agreement, DePuy Synthes Companies and the AO will continue to work together to make meaningful contributions to global health care.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings